pimagedine has been researched along with Cranial Nerve II Diseases in 2 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pang, IH | 1 |
| Johnson, EC | 1 |
| Jia, L | 1 |
| Cepurna, WO | 1 |
| Shepard, AR | 1 |
| Hellberg, MR | 1 |
| Clark, AF | 1 |
| Morrison, JC | 1 |
| Ino-ue, M | 1 |
| Ohgiya, N | 1 |
| Yamamoto, M | 1 |
2 other studies available for pimagedine and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage.
Topics: Aged; Animals; Caenorhabditis elegans Proteins; Disease Models, Animal; Enzyme Inhibitors; Gene Expr | 2005 |
Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats.
Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relation | 1998 |